Tizi Ouzou plant to start production of new drug in 2015

The Oued Aissi Plant (Tizi Ouzou), coming under Novo Nordisk laboratories will start production of new drug for diabetes patients in 2015, unveiled Wednesday in Vienna (Austria), new CEO of Novo Nordisk Algeria, Peter Ulvskjold.
The Oued Aissi plant which produces Metformine as part of the Algerian-Danish Partnership will start soon the production of NovoNorm, Ulvskjold told APS on the 50th annual meeting of European Association for the Study of Diabetes (EASD), taking place in Vienna from 15 to 19 September.
Created in 2006, this plant is fully managed by Algerian skills and is being currently equipped for the manufacturing of NovoNorm next year, he said, calling the manufacturing of this new drug a "new milestone" in the partnership between Algeria and the Danish laboratories Novo Nordisk.
Now, the plant produces 30 million boxes of Metformine, he said. After meeting the needs of the national market, the plant "will export to African countries," the same official added.
Concerning the partnership with Saidal for the manufacturing of insulin, Ulvskjold announced that it will be produced in Constantine Plant and will be sold next year.
In the beginning, the plant will produce 10% of classic insulin, before producing modern insulin as from 2016.
Regarding the partnership with the Ministry of Health, Population and Hospital Reform, the official cited the project of a mobile clinic that traveled since its launch in 2011 in several provinces of the country. It aims to provide early diagnosis of diabetes and awareness.
Ulvskjold expressed willingness to continue fulfilling the projects agreed with the Algerian government.